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Characteristics of T-Lymphocytes
Infiltrating Human B-Cell Lymphomas
by Peter Marquardt* and Hans Konrad Muller-Hermelink*
Using a recently described technique for direct expansion of human T-lymphocytes isolated from small
intestine biopsies, we have investigated the local cellular immune response in six patients with B-cell
lymphomas of various subtypes. T-cell lines (TCL) were established by seeding tumor-infiltrating T-lym-
phocytes (TITL) at limitingdilution in the presence ofirradiated feedercells in culture medium containing
rIl-2 and phytohemagglutinin (PHA). About l/5o T-cells gave rise to a TCL; they all were CD3+. The CD4/
CD8 ratio was 3.8:1 before and after cloning. Of 45 TCLs analyzed so far from one patient with B-cell
lymphoma of the lung, 4 were cytotoxic as shown by their ability to exert lectin-dependent cytotoxicity
against allogeneic target cells. Ofthese, 3 demonstrated specificity for the autologous malignant B-cells.
Five TCLs lysed the NK-sensitive K562 cell line in a HLA-unrestricted manner. When tested for antigen-
specific proliferative activity, 4 TCLs only responded to the autologous lymphomacells, but 5TCLs reacted
to the autoantigenic ganglioside GMI, Southern Blot analyses did not show a clonal pattern of T-cell
receptor gene rearrangement within all TITL populations. The peripheral T-lymphocytes ofthe lymphoma
patients showed a drastically reduced response to the mitogens PHA, Concanavalin A, and pokeweed
mitogen. The present report demonstrates that it is possible to analyze TITL at clonal level. Thistechnique
may be the only means ofinvestigating the specificity ofthe TITL and may help us to identify the relevant
tumor-associated autoantigens iftumor-induced autoimmunization is indeed one of the mechanisms that
control the growth of tumors and metastases.
Introduction
Tumor-infiltrating leukocytes, which are usually
found in neoplastic tissue, have attracted the interest
of many immunologists (1). Among the components of
the lymphoreticular infiltrate of malignancies, macro-
phages have been studied most extensively. Other re-
searchers are looking for tumor-specific monoclonal an-
tibodies in order to trace tumor-associated antigens and
for therapeutical reasons. However, T-lymphocytes
represent the major component ofthese infiltrates. The
greatly increased incidence of lymphomas in circum-
stances of immunosuppression (2-4) has prompted us
to study the role of T-lymphocytes infiltrating human
B-cell lymphomas. In view ofthe compartmentalization
of T-cell immunity, it is possible that the relevant T-
cells may be sequestered into the malignant lesion (5).
Therefore, itis essentialfor ustostudythelocalimmune
response by using tumor-infiltrating T-lymphocytes
(TITL) and not just simply the easily accessible pe-
ripheral blood lymphocytes (PBL) ofthe patients (5,6).
Our previous reports of a high enrichment of virus-
specific HLA-restricted T-cells at the site of inflam-
mation during the acute phase of viral infections was
*Institute of Pathology, University of Wurzburg, D-8700 Wurz-
burg, Federal Republic of Germany.
Address reprint requests to P. Marquardt, Institute ofPathology,
University ofWurzburg, D-8700 Wurzburg, Federal Republic ofGer-
many
an important observation, suggesting that the infor-
mationobtainedfromclonedlocalT-cellpopulations(Ta-
ble 1) is in fact reliable (7).
Experimental Protocol
In vivo activated TITL were always directly cloned
and expanded without any prior in vitro restimulation
with lymphoma cells but in the presence of phytohem-
agglutinin (PHA); we therefore may assume that no
selection for certain subpopulations or certain specific-
ities occurred beforethe cloningprocedure, and random
growth of TITL could be expected (5,6). As not all ex-
Table 1. Local cellular immune reactivity patterns in different
inflammatory conditions.
Viral infections Multiple B-cell
Parameter Acute Chronic sclerosis lymphomas
Proliferating frequency 0.025 0.026 0.04-0.06 0.01-0.03
Phenotype
CD4+ 20% 66% 75-100% 73.7%
CD8+ 80% 34% 0-25% 26.3%
Antigen-specific 88% 7.0% 11.6%
Proliferative 6% 2.7% 6.6%
Cytotoxic 82% 4.3% 5.0%
Autoreactive
Proliferative - 8.7% - 25% 8.3%
LDCC NTa 45% - 50% 6.6%
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panded T-cell populations were monoclonal in the strict
sense of the word, the term TCL will be used. The
growing TCLs were analyzed for proliferating fre-
quency by using Lefkovits calculation and were ana-
lyzed forphenotype byusingmonoclonal antibodies spe-
cific for T-cell subpopulations (CD3, CD4, CD8) and
HLA-DR. TCLs were analyzed for function by using
conventional cytotoxicity assays and analyzed for spe-
cific reactivity by using proliferation assays against the
malignant B-cells andtheautoantigens actin, cardiolipin
(phospholipid), and varioustumor-associated glycolipids
(GM1, GDla, GTl, Ll-A). Southern Blot analyses were
carried out using conventional techniques (8).
Results
The analysis of B-cell lymphoma-infiltrating T-cells
revealed patterns of reactivity as far as proliferating
frequency, phenotype, functions, antigen-specificities,
and restriction elements were concerned that were al-
most identical to our previous observations in patients
with chronic viral infections, autoimmune diseases (Ta-
ble 1), and gastric carcinomas (7,9,10). In 6 patients
with B-cell lymphomas of various subtypes, about 1 in
50 T-cells gave rise to a TCL (proliferating frequency
0.02) (Fig. 1); they all were CD3+. As compared to
normal PBL, all ofwhich grow under these culture con-
ditions (11),' this poor response to PHA indicates a re-
duced proliferative capacity ofthe TITL. A substantial
HLA-DR+ fraction of TITL had obviously been acti-
vated in vivo. There is a predominance ofCD4+ T-cells
in the infiltrate. The CD4/CD8 ratio was 3.8:1 before
and after cloning, suggesting that there is no selection
forcertain subpopulations due to ourcloningprocedure.
Out of 45 TCLs analyzed so far from one patient with
B-cell lymphoma ofthe lung, 4 were cytotoxic as shown
by their ability to exert lectin-dependent cytotoxicity
(LDCC) against allogeneic target cells. Ofthese, 3 dem-
onstrated cytotoxicity specific for the autologous malig-
nant B-cells (2 of which were CD4+). Five TCLs lysed
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FIGURE 1. Limiting dilution ofT-lymphocytes infiltrating human B-
cell lymphomas. Wells were screened for colonies on days 6, 10,
14, and 21 after seeding. A well was scored positive ifone-fourth
ofits surface was covered with growing cells. Each value is based
on the evaluation of at least 200 wells.
the NK-sensitive K562 cell line in a HLA-unrestricted
manner.
All TCLs were also tested for proliferative reactivity
to the autologous lymphoma cells, but only four TCLs
(CD4+) responded with a3.3-, 3.5-, 6.0-, and 66-fold 3H-
TdR incorporation (Table 2). When tested against tu-
mor-associated glycolipids, five TCLs (CD4+) reacted
to the autoantigenic ganglioside GM, with stimulation
indices of3.3 x, 4.5 x, 5.0 x, 5.2 x, and 8.8 x (Table
2). Though not identified sufficiently in this study, the
restriction elements are most likely class II HLA mol-
ecules.
Usingcells directly afterisolationfromthe lymphoma
tissue (-35% TITL), Southern Blot analyses did not
reveal aclonalTcR generearrangement withinallTITL
populations (sensitivity :3%). ThePBL ofalllymphoma
patients showed a drastically reduced response to mi-
togens (PHA, Concavalin A, pokeweed mitogen) (Table
3).
Discussion
The present report describes for the first time the
establishment ofTCLs directly fromsurgicallyresected
Table 2. Proliferative response of CD4+ TCLs derived from
cloned TITL from a patient with B-cell lymphoma.
Antigen specificity Medium PHA
Autologous lymphoma cells
15410a 234 28428
3440 5728 3330
697 198 5439
725 222 6794
Ganglioside GM.
4890 1083 8112
627 188 6222
1911 218 4549
883 274 11015
856 171 3924
aAll numbers represent cpm 3H-TdR uptake.
Table 3. Proliferative response of autologous PBL to mitogens
in whole blood cultures.a
Maximal cpm 3H-TdR uptake/PBL
in response to
PBL source PHA Con A PWM
Normals, n = 20 11.13 2.74 3.86
(0.57)b (0.26) (0.16)
Chronic viral infection (RB) 5.48 1.78 2.76
Morbus Hodgkin type I 3.02 1.81 1.26
(KG)
T-cell lymphoma, low grade 0.97 1.20 0.35
(JK)
B-cell lymphomas
High grade (PR) 6.29 1.83 2.59
Low grade (BR) 1.48 0.76 1.46
Low grade (FL) 0.05 0.94 0.19
Low grade (IS) 5.66 1.58 1.88
aMitogens are PHA, Concavalin A (Con A), and pokeweed mitogen
(PWM). Letters in parentheses are patients' initials.
bNumbers in parentheses are SEM.
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human B-cell lymphoma tissue. In contrast to 100%
growth of normal PBL (11), identical proliferating fre-
quencies of infiltrating T-cells in various chronic dis-
eases [viral infections (9), autoimmune diseases (7), gas-
tric cancers (10), and B-cell lymphomas] argue against
a tumor-induced unresponsiveness in the tumor envi-
ronment. However, reduced responses, also ofthe pa-
tients' PBL to mitogens (Table 3), suggest a nonspecific
immunodeficiency state (12). Our previous results as to
T-cell reactivity in chronic inflammatory conditions
where CD4+ T-cells represent the major component of
the infiltrate (7) indicate that the incidence of B-lym-
phoma-reactive T-cells in such a similarly protracted
disease of long duration may be extremely low. This
conforms to observations of other groups (13). Thus,
and in accordance with a polyclonal TcR gene rear-
rangement within the TITL populations, it is question-
able whether one should test hundreds of clones for
tumor reactivity. We favor the view that HLA class I-
restricted cytotoxic T-cells ofthe CD8+ phenotype, spe-
cific for the etiological agent, are limited to the initial
phase ofanacuteinflammation (Table 1), whereasCD4+
cells are a hallmark of a chronic inflammatory process
(9). The function of the CD4+ TITL has yet to be de-
fined. Whether they are cytotoxic ornoncytotoxic, they
obviously do not recognize an antigen on the tumor cell
surface bywhichthemalignantcells areeliminatedfrom
the host. According to the literature, they might even
have suppressive activity (14-16). Therefore, cloning
TITL may be the only means ofinvestigating the spec-
ificity of these CD4+ T-cell populations and of finding
out whether they respond to tumor-associated autoan-
tigens (e.g., glycolipids, glycoproteins). In order to
maintain self-tolerance, such ubiquitous autoantigens,
known to be highly expressed on certain tumor cell sur-
faces, have to be protected bythe immune system. Con-
sequently, theywould have toinduce T-suppressor cells
(probably the CD4+ TITL population) that would facil-
itate oncogenesis by suppressing antitumor (anti-self)
reactivity (14-16). Allowing malignant cells to escape
from the immune system would be an important way
by which immune effectors could produce tumor pro-
gression.
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